Pulmonary vascular dysfunction in preterm lambs with chronic lung disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 1 29-1, 2003, Pages

  Bland, Richard D ^a   Ling, Con Yee ^b   Albertine, Kurt H ^b   Carlton, David P ^c   MacRitchie, Amy J ^b   Day, Ronald W ^b   Dahl, Mar Janna ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bronchopulmonary dysplasia; Inhaled nitric oxide; Neonatal lung injury; Newborn sheep; Pulmonary circulation; Pulmonary vascular resistance; Soluble guanylate cyclase

Indexed keywords

8 BROMO CYCLIC GMP; ELASTIN; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LAMB; LUNG BLOOD FLOW; LUNG DYSPLASIA; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR DISEASE;

EID: 0038338403     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00395.2002     Document Type: Article

References (63)

1. Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman CM, and Wiggins JW. Pulmonary vascular response to oxygen in infants with severe BPD. Pediatrics 75: 80-84, 1985.
2. Albertine KH, Jones GP, Starcher BC, Bohnsack JF, Davis PL, Cho S, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med 159: 945-958, 1999.
3. Archer S. Measurement of nitric oxide in biological models. FASEB J 7: 349-360, 1993.
4. Behrends S, Kempfert J, Mietens A, Koglin M, Scholz H, and Middendorff R. Developmental changes of nitric oxide-sensitive guanylyl cyclase expression in pulmonary arteries. Biochem Biophys Res Commun 283: 883-887, 2001.
5. Berman W, Yabek SM, Dillon T, Burstein R, and Corlew S. Evaluation of infants with BPD using cardiac catheterization. Pediatrics 70: 708-712, 1982.
6. Black SM, Johengen MJ, and Soifer SJ. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr Res 44: 821-830, 1998.
7. Bland RD, Albertine KH, Carlton DP, Kullama L, Davis P, Cho SC, Kim BI, Dahl M, and Tabatabaei N. Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 48: 64-74, 2000.
8. Bloch KD, Filippov G, Sanchez LS, Nakane M, and de la Monte SM. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol Lung Cell Mol Physiol 272: L400-L406, 1997.
9. Bonikos DS, Bensch KG, Northway WH Jr, and Edwards DK. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 7: 643-666, 1976.
10. Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, and Black SM. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683-691, 2003.
11. Bush A, Busst CM, Knight WB, Hislop AA, Haworth SC, and Shinebourne EA. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 65: 739-745, 1990.
12. Carlton DP, Albertine KH, Cho SC, Lont M, and Bland RD. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol 83: 1307-1317, 1997.
13. Carvajal JA, Germain AM, Huidobro-Toro JP, and Weiner CP. Molecular mechanisms of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420, 2000.
14. Chambers HM and van Velzen D. Ventilator-related pathology in the extremely immature lung. Pathology 21: 79-83, 1989.
15. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, and Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 342: 469-474, 2000.
16. Coalson JJ. Pathology of chronic lung disease of early infancy. In: Chronic Lung Disease in Early Infancy, edited by Bland RD and Coalson JJ. New York: Dekker, 2000, p. 85-124.
17. Coalson JJ, Winter VT, Gerstmann DR, Idell S, King RJ, and deLemos RA. Pathophysiologic, morphometric, and biochemical studies of the preterm baboon with bronchopulmonary dysplasia. Am Rev Respir Dis 145: 872-881, 1992.
18. D'Angelis CA, Nickerson PA, Steinhorn RH, and Morin FC III. Heterogeneous distribution of soluble guanylate cyclase in the pulmonary vasculature of the fetal lamb. Anat Rec 250: 62-69, 1998.
19. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhites J, Chang CT, and the INO Study Group/PPHN. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 101: 325-334, 1998.
20. Franco-Belgium Nitric Oxide Trial Group. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet 354: 1066-1071, 1999.
21. Frostell C, Fratacci MD, Wain JC, Jones R, and Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
22. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
23. Gibson QH and Roughton FJW. The kinetics of equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 136:507-526, 1957.
24. Hislop A and Haworth S. Pulmonary vascular damage in the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 9: 152-161, 1990.
25. Holzmannk, A, Bloch KD, Sanchez LS, Fillipov G, and Zapol WM. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol Lung Cell Mol Physiol 271: L981-L986, 1996.
26. Husain AN, Siddiqui NH, and Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29: 710-717, 1998.
27. Kinsella JP, Ivy DD, and Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res 36: 402-408, 1994.
28. Kinsella JP, Neish SR, Shaffer E, and Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820, 1992.
29. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, and Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41: 457-463, 1997.
30. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, and Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomized controlled trial. Lancet 354:1061-1065, 1999.
31. Kiyozo M, Ihnken K, Buckberg GD, Sherman MP, Young HH, and Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 93: 2658-2666, 1994.
32. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, and Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 94: 578-584, 1994.
33. Kurrek MM, Zapol WM, Holzmann A, Filippov G, Winkler M, and Bloch KD. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. Am J Physiol Lung Cell Mol Physiol 269: L618-L624, 1995.
34. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
35. MacRitchie AN, Albertine KH, Sun J, Lei PS, Jensen SC, Freestone AA, Clair PM, Dahl MJ, Godfrey EA, Carlton DP, and Bland RD. Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 281: L1011-L1020, 2001.
36. Margraf LR, Tomashefski JF, Bruce MC, and Dahms BB. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 143: 391-400, 1991.
37. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, and Gluck L. Elastase and α-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest 72: 656-666, 1983.
38. Morin FC III. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25: 245-250, 1989.
39. Nakade M, Arai K, Saheki S, Kuno T, Buechler W, and Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265: 16841-16845, 1990.
40. Northway WH Jr, Rosan RC, and Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 276:357-368, 1967.
41. Oda H, Susumoto S, and Nakajima T. Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health 30: 453-455, 1975.
42. Ogden BE, Murphy SA, Saunders GC, Pathak D, and Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130: 817-821, 1984.
43. Pierce RA, Albertine KH, Starcher B, Bohnsack JF, Kullama L, Carlton DP, and Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol Lung Cell Mol Physiol 272: L452-L460, 1997.
44. Rimar S and Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88: 2884-2887, 1993.
45. Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A, Bloch K, PolanerD, and Zapol W. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 72: 246-254, 1993.
46. Roberts JD Jr, Chiche JD, Weimann J, Steudel W, Zapol WM, and Bloch KD. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res 87:140-145, 2000.
47. Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, and Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336: 605-610, 1997.
48. Roberts JD Jr, Polaner DM, Lang P, and Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818-819, 1992.
49. Roberts JD Jr, Roberts CT, Jones RC, Zapol WM, and Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy and growth retardation in the hypoxic newborn rat. Circ Res 76: 215-222, 1995.
50. Rosenberg RB, Broner CW, and O'Dorisio MS. Modulation of cyclic guanosine monophosphate production during Escherichia coli septic shock. Biochem Med Metab Biol 51: 149-155, 1994.
51. Scott WS and Nakayama DK. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res 80: 309-314, 1998.
52. Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, and Morin FC III. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 272: L1005-L1012, 1997.
53. Smith PK, Krohn RI, Hermanson GT, Mallia AK, and Gartner FH. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
54. Stocker JT. Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants. Hum Pathol 17: 943-961, 1986.
55. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336: 597-604, 1997.
56. Thomae KR, Nakayama DK, Billiar TR, Simmons RL, Pitt BR, and Davies P. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. J Surg Res 59: 337-343, 1995.
57. Tiktinsky MH, Cummings JJ, and Morin FC III. Acetylcholine increases pulmonary blood flow in intact fetuses via endothelium-dependent vasodilation. Am J Physiol Heart Circ Physiol 262: H406-H410, 1992.
58. Tomashefski JF, Oppermann HC, and Vawter GF. BPD: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 2: 469-487, 1984.
59. Tzao C, Nickerson PA, Russell JA, Gugino SF, and Steinhorn RH. Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs. Pediatr Pulmonol 31: 97-105, 2001.
60. Van Lierde S, Cornelis A, Devlieger H, and Moerman P. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? Biol Neonate 60: 152-162, 1991.
61. Wild LM, Nickerson PA, and Morin FC III. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25: 251-257, 1989.
62. Zar J. Biostatistical Analysis (2nd ed.). Englewood Cliffs, NJ: Prentice-Hall, 1984, p. 162-235.
63. Zayek M, Cleveland D, and Morin FC III. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr 122: 743-750, 1993.